Home / Creating a SOX Compliance Program for a Newly Public Pharma Company
A newly public, pre-revenue biopharmaceutical company engaged SolomonEdwards to develop its Year 1 program for compliance with Sarbanes-Oxley 404. The client wanted to ensure it had a stringent compliance program capable of ongoing annual assessments and external auditor reliance.
Drawing upon industry acumen and best practices, we provided a comprehensive SOX compliance program to both improve operational efficiency and meet regulatory standards, thereby securing a strategic advantage for the firm during the pivotal early stages of public investment. Key elements of the program included:
SolomonEdwards’ development of the company’s SOX compliance program enabled strict adherence to regulatory standards while also enhancing operations. The compliance program has given the company a solid foundation for ongoing compliance and for external audit reliance on management testing. These efforts also enabled the company to successfully complete the Year 1 SOX 404 assessment, develop an efficient and robust SOX compliance program, and identify recommendations for future optimization efforts.
Join our monthly newsletter for insightful articles from our subject matter experts, along with real-world case studies showcasing our impact.